2nd AACR-KCA Joint Conference on Precision Medicine in Solid Tumors
Nov. 10-11, 2021 (Eastern Standard Time) / Nov. 11-12, 2021 (Korean Standard Time)
Seoul, Korea (in-person and virtual formats)
William C. Hahn, Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Dong-Wan Kim, Seoul National University, Seoul, Korea
The American Association for Cancer Research (AACR) and the Korean Cancer Association (KCA) will present our second joint conference this November, both in-person in Seoul and in virtual format. This program will unite basic, translational and clinical researchers, as well as researchers working on the development of new targeted therapeutics from across the globe. The program will focus broadly on precision cancer medicine, with an emphasis on solid tumors, and feature the Waun Ki Hong Memorial Lecture. Session topics will include clinical trials in the IO era, proteogenomics, preclinical models, precision medicine in immuno-oncology, targeting the RAS pathway, and novel discoveries in drug screening.